These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 9216635
1. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation. Jakowlew SB, Moody TW, Mariano JM. Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635 [Abstract] [Full Text] [Related]
2. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW. Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633 [Abstract] [Full Text] [Related]
3. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C. Cancer Res; 1996 Jan 01; 56(1):44-8. PubMed ID: 8548772 [Abstract] [Full Text] [Related]
4. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis. Mariano JM, Montuenga LM, Prentice MA, Cuttitta F, Jakowlew SB. Int J Dev Biol; 1998 Nov 01; 42(8):1125-36. PubMed ID: 9879710 [Abstract] [Full Text] [Related]
5. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP. Kim IY, Zelner DJ, Lee C. Exp Cell Res; 1998 May 25; 241(1):151-60. PubMed ID: 9633523 [Abstract] [Full Text] [Related]
6. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y, Kyprianou N. Cell Growth Differ; 1998 Feb 25; 9(2):185-93. PubMed ID: 9486855 [Abstract] [Full Text] [Related]
7. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y, Kyprianou N. Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572 [Abstract] [Full Text] [Related]
10. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S. Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799 [Abstract] [Full Text] [Related]
11. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Joyce NC, Harris DL, Mello DM. Invest Ophthalmol Vis Sci; 2002 Jul 15; 43(7):2152-9. PubMed ID: 12091410 [Abstract] [Full Text] [Related]
12. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone. Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C. Exp Cell Res; 1996 Jan 10; 222(1):103-10. PubMed ID: 8549651 [Abstract] [Full Text] [Related]
18. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines. Zeinoun Z, Teugels E, De Bleser PJ, Neyns B, Geerts A, De Greve J. Anticancer Res; 1999 Jan 10; 19(1A):413-20. PubMed ID: 10226576 [Abstract] [Full Text] [Related]